Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/8372
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-06-30T22:18:00Z-
dc.date.available2022-06-30T22:18:00Z-
dc.date.issued2016-05-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/8372-
dc.publisherINCApt_BR
dc.subjectVacinas contra Papillomaviruspt_BR
dc.subjectPapillomavirus Vaccinespt_BR
dc.subjectVacunas contra Papillomaviruspt_BR
dc.subjectRedução de Custospt_BR
dc.subjectCost Savingspt_BR
dc.subjectAhorro de Costopt_BR
dc.subjectNeoplasias/prevenção & controlept_BR
dc.subjectNeoplasms/prevention & controlpt_BR
dc.subjectNeoplasias/prevención & controlpt_BR
dc.subjectTelemedicinapt_BR
dc.subjectTelemedicinept_BR
dc.titleCurtaspt_BR
dc.title.alternativeInforme INCA 347pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 347

Files in This Item:
File Description SizeFormat 
Informe-INCA-2016-347-2-Curtas.pdf787.7 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.